| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1113185280 |
| P356 | DOI | 10.1007/S11906-019-0937-8 |
| P932 | PMC publication ID | 6449495 |
| P698 | PubMed publication ID | 30949864 |
| P2093 | author name string | A H Jan Danser | |
| Xifeng Lu | |||
| Liwei Ren | |||
| P2860 | cites work | Protective effects of the angiotensin II AT2 receptor agonist compound 21 in ischemic stroke: a nose-to-brain delivery approach. | Q51745079 |
| Renin- and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur? | Q53210609 | ||
| Studies on angiotensinogen of plasma and cerebrospinal fluid in normal and hypertensive human subjects | Q71267920 | ||
| Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor? | Q81356302 | ||
| Multiple ascending dose study with the new renin inhibitor VTP-27999: nephrocentric consequences of too much renin inhibition | Q87177658 | ||
| The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke | Q87255898 | ||
| Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage | Q87364788 | ||
| Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor | Q89179165 | ||
| Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice | Q90836305 | ||
| Selective Deletion of the Brain-Specific Isoform of Renin Causes Neurogenic Hypertension | Q30275701 | ||
| Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats | Q30437186 | ||
| Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation | Q33205413 | ||
| Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier | Q33842137 | ||
| Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts | Q33844005 | ||
| Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients? | Q34453476 | ||
| Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke | Q35738095 | ||
| A Salt-Induced Reno-Cerebral Reflex Activates Renin-Angiotensin Systems and Promotes CKD Progression | Q35790573 | ||
| Liver angiotensinogen is the primary source of renal angiotensin II. | Q36050931 | ||
| Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein | Q36470843 | ||
| Aminopeptidase A inhibitors as potential central antihypertensive agents | Q36675846 | ||
| Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension | Q36992645 | ||
| Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin | Q37161448 | ||
| Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: yes. | Q37567195 | ||
| Neuron-specific (pro)renin receptor knockout prevents the development of salt-sensitive hypertension | Q37626138 | ||
| Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro | Q37731227 | ||
| The Role of the (Pro)renin Receptor in Hypertensive Disease | Q38428278 | ||
| Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension | Q38637276 | ||
| Reno-Cerebral Reflex Activates the Renin-Angiotensin System, Promoting Oxidative Stress and Renal Damage After Ischemia-Reperfusion Injury | Q39057673 | ||
| (Pro)renin receptor as a therapeutic target for the treatment of cardiovascular diseases? | Q39191078 | ||
| Mineralocorticoid and angiotensin II type 1 receptors in the subfornical organ mediate angiotensin II - induced hypothalamic reactive oxygen species and hypertension | Q40762004 | ||
| Distinct renin isoforms generated by tissue-specific transcription initiation and alternative splicing | Q40975383 | ||
| AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation | Q41819451 | ||
| The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. | Q41935568 | ||
| Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism | Q42716918 | ||
| Renal Atp6ap2/(Pro)renin Receptor Is Required for Normal Vacuolar H+-ATPase Function but Not for the Renin-Angiotensin System. | Q42722913 | ||
| Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats | Q42972308 | ||
| Subcellular localization of angiotensin II in kidney and adrenal | Q43591393 | ||
| Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation | Q44488209 | ||
| (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice from Diet-Induced Obesity and Hepatosteatosis. | Q47231495 | ||
| Central and Peripheral Slow-Pressor Mechanisms Contributing to. | Q47416221 | ||
| Angiotensin II Type 2 Receptor and Receptor Mas Are Colocalized and Functionally Interdependent in Obese Zucker Rat Kidney | Q47924559 | ||
| Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats. | Q48088455 | ||
| Immunocytochemical localization of angiotensinogen in the rat brain | Q48089905 | ||
| Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis | Q48182833 | ||
| The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes | Q48350561 | ||
| Astrocytes Contribute to Angiotensin II Stimulation of Hypothalamic Neuronal Activity and Sympathetic Outflow | Q48489132 | ||
| Angiotensin-forming enzyme in brain tissue | Q48805828 | ||
| Adipocytes do not significantly contribute to plasma angiotensinogen. | Q49793034 | ||
| Brain Renin-Angiotensin System: Does It Exist? | Q51064303 | ||
| Identification of the (Pro)renin Receptor as a Novel Regulator of Low-Density Lipoprotein Metabolism. | Q51740281 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| sympathetic nervous system | Q187215 | ||
| brain renin-angiotensin system | Q15311907 | ||
| P304 | page(s) | 28 | |
| P577 | publication date | 2019-04-04 | |
| P1433 | published in | Current Hypertension Reports | Q15746362 |
| P1476 | title | Revisiting the Brain Renin-Angiotensin System-Focus on Novel Therapies | |
| P478 | volume | 21 |
| Q94571148 | COVID-19, Angiotensin Receptor Blockers, and the Brain |
| Q98775878 | Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2 |
| Q92566054 | The Renin-Angiotensin System in the Central Nervous System and Its Role in Blood Pressure Regulation |
Search more.